Literature DB >> 35084510

[Update of the Surviving Sepsis Campaign guidelines 2021-What is new?]

Josef Briegel1, Patrick Möhnle2.   

Abstract

The revised and redefined "International Guidelines for Management of Sepsis and Septic Shock 2021" of the Surviving Sepsis Campaign were published on 4 October 2021. As in the previous version from 2016, the focus of these international guidelines is on the diagnosis and acute treatment measures in sepsis. The topics long-term outcome and treatment targets for rehabilitation are extensively discussed and accompanied by specific recommendations. These recommendations and the underlying studies reflect the increasing awareness about the long-term consequences of severe diseases requiring intensive medical care. This article summarizes the updates in a clearly comprehensible form.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Anti-infective agents; Hemodynamics; Long-term outcome; Screening; Time-to-treatment

Mesh:

Year:  2022        PMID: 35084510     DOI: 10.1007/s00101-022-01087-x

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  1 in total

1.  [Practice of pharmaceutical thrombosis prophylaxis and anticoagulation in patients with sepsis and pre-existing anticoagulation or heparin-induced type II thrombocytopenia-Results of a nationwide survey in German intensive care units].

Authors:  Thomas Schmoch; Thorsten Brenner; Andrea Becker-Pennrich; Ludwig Christian Hinske; Markus A Weigand; Josef Briegel; Patrick Möhnle
Journal:  Anaesthesist       Date:  2021-08-05       Impact factor: 1.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.